FiercePharma2d
Bristol Myers angles Breyanzi for another blood cancer as it works to close Gilead's CAR-T lead
With another trial win, Bristol Myers Squibb is touting Breyanzi as the CD19-directed CAR-T therapy with positive readouts in the most cancer types. | With another trial win, Bristol Myers Squibb is ...
UIC scientists redesign asparaginase to minimize leukemia treatment side effects
University of Illinois Chicago scientists have redesigned a treatment for the most common pediatric leukemia to eliminate its severe side effects, like blood clots and liver damage.
Nature10y
Long-term outcome of a pediatric-inspired regimen used for adults aged 18–50 years with newly diagnosed acute lymphoblastic leukemia
On the basis of the data suggesting that adolescents and young adult patients with acute lymphoblastic leukemia (ALL ... fewer than five white blood cells on CSF cell count, with blasts on ...